Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Steve Research who wrote (5320)	8/20/1998 11:12:00 PM
From: Peter V	Read Replies (1) \| Respond to of 7041

I think the problem here Steve, is that the drug is intended to be used for those men having ED, not healthy men. The studies with Vasomax in men with ED show it to be only marginally more effective than a placebo, and that is what matters here. So if you have ED, we would be more apt to accept your claim that this drug works for you and others with ED (although we reserve the right to be skeptical of your claims). Although I'm not sure I would be taking non-FDA approved drugs to determine whether to invest in a particular company, I'd rather rely on research reports.

To: Steve Research who wrote (5320)	8/20/1998 11:12:00 PM
From: Bradpalm1	Read Replies (2) \| Respond to of 7041

What does your anecdotal experience with this drug have to do with its chances for ultimate FDA approval? If you're an example of Zonagen's "heavy artillery" they're in DEEP trouble. Bradpalm1